ZENOBE GRAMME (ZEN.BR) Stock Fundamental Analysis
Europe - Euronext Brussels - EBR:ZEN - BE0003809267 - Common Stock
220 EUR
+4 (+1.85%)
We assign a fundamental rating of 2 out of 10 to ZEN. ZEN was compared to 72 industry peers in the Real Estate Management & Development industry. ZEN may be in some trouble as it scores bad on both profitability and health. ZEN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year ZEN has reported negative net income.
In the past 5 years ZEN reported 4 times negative net income.
In the past 5 years ZEN always reported negative operating cash flow.
1.2 Ratios
ZEN has a Return On Assets (-0.11%) which is in line with its industry peers.
With a Return On Equity value of -12.00%, ZEN is not doing good in the industry: 68.06% of the companies in the same industry are doing better.
ZEN has a better Return On Invested Capital (12.15%) than 97.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.11% | ||
| ROE | -12% | ||
| ROIC | 12.15% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ZEN has a Operating Margin of 47.78%. This is in the better half of the industry: ZEN outperforms 75.00% of its industry peers.
In the last couple of years the Operating Margin of ZEN has declined.
ZEN does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 47.78% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y-3.97%
OM growth 5Y-3.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ZEN has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ZEN has less shares outstanding
Compared to 1 year ago, ZEN has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.21, we must say that ZEN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.21, ZEN perfoms like the industry average, outperforming 59.72% of the companies in the same industry.
A Debt/Equity ratio of 78.50 is on the high side and indicates that ZEN has dependencies on debt financing.
The Debt to Equity ratio of ZEN (78.50) is worse than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 78.5 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.21 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 0.27 indicates that ZEN may have some problems paying its short term obligations.
With a Current ratio value of 0.27, ZEN is not doing good in the industry: 84.72% of the companies in the same industry are doing better.
ZEN has a Quick Ratio of 0.27. This is a bad value and indicates that ZEN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ZEN (0.27) is worse than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.27 | ||
| Quick Ratio | 0.27 |
3. Growth
3.1 Past
ZEN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.43%.
Measured over the past years, ZEN shows a small growth in Revenue. The Revenue has been growing by 2.07% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.91%
Revenue 1Y (TTM)0.43%
Revenue growth 3Y3.39%
Revenue growth 5Y2.07%
Sales Q2Q%1.67%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
ZEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.69%, ZEN is a good candidate for dividend investing.
ZEN's Dividend Yield is rather good when compared to the industry average which is at 4.27. ZEN pays more dividend than 83.33% of the companies in the same industry.
ZEN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.69% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
EBR:ZEN (12/19/2025, 7:00:00 PM)
220
+4 (+1.85%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.20M
Revenue(TTM)2.15M
Net Income(TTM)-9.60K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.69% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 6.13 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 188.57 | ||
| P/tB | 188.57 | ||
| EV/EBITDA | N/A |
EPS(TTM)-95.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS35.88
BVpS1.17
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.11% | ||
| ROE | -12% | ||
| ROCE | 16.2% | ||
| ROIC | 12.15% | ||
| ROICexc | 12.15% | ||
| ROICexgc | 12.15% | ||
| OM | 47.78% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-5.25%
ROICexgc growth 5Y1.71%
ROICexc growth 3Y-5.25%
ROICexc growth 5Y1.71%
OM growth 3Y-3.97%
OM growth 5Y-3.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 78.5 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.27 | ||
| Quick Ratio | 0.27 | ||
| Altman-Z | 1.21 |
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.43%
Revenue growth 3Y3.39%
Revenue growth 5Y2.07%
Sales Q2Q%1.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.96%
EBIT growth 3Y-0.71%
EBIT growth 5Y-1.79%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A
ZENOBE GRAMME / ZEN.BR FAQ
Can you provide the ChartMill fundamental rating for ZENOBE GRAMME?
ChartMill assigns a fundamental rating of 2 / 10 to ZEN.BR.
What is the valuation status for ZEN stock?
ChartMill assigns a valuation rating of 0 / 10 to ZENOBE GRAMME (ZEN.BR). This can be considered as Overvalued.
Can you provide the profitability details for ZENOBE GRAMME?
ZENOBE GRAMME (ZEN.BR) has a profitability rating of 2 / 10.